Global Neuromodulation Devices Market Analysis & Trends - Industry Forecast to 2030

Global Neuromodulation Devices Market Analysis & Trends - Industry Forecast to 2030

Neuromodulation Devices: Market Size

From $32.09 billion in 2024, the global Neuromodulation Devices market is projected to reach $167.45 billion by 2030. Based on our analysis the market is expected to grow at a CAGR of 31.7% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include rising prevalence of neurological disorders, adoption of advanced methodologies for treating various diseases and growing research and technological developments.

Global Neuromodulation Devices Market: Market Dynamics

Neuromodulation devices ‘neurostim’ are used to recover the value of life of people suffering from several conditions, long-lasting pain, vital tremor, psychological disorders, urinary and fecal incontinence and dystonia. For shoulder pain neuromodulation devices are available in market. Besides that, pediatric neuromodulation devices and neuromodulation devices for TBI are in vast demand with growing diseases in children and brain injuries. The situations are enduring, so the clinical period for neuromodulation devices is long-term. Neuromodulation therapy devices can straight work on the nerves, and they can change the nerve activity to a target area by sending an electrical agent to the area. Neuromodulation devices can treat nearly every disease, and it will raise the neuromodulation devices market. The rise in neurological disorders globally is one of the key factors contributing to the growth of market.

For instance, Huashan Hospital in Shanghai, China directed trials for setting up treatment for disorder of consciousness (DOC) using spinal cord stimulation. Similarly, in 2017, USFDA approved Inspire 3028 – an upper airway stimulation device by Inspire Medical Systems Inc., for treatment of sleep apnea. The device is anticipated to cure sleep apnea in patients who are continuous positive airway pressure therapy (CPAP) resistant.

On the other hand, lack of awareness about the presence of a neuromodulation device is likely to obstruct the profit boundaries. In addition, the rise in investments in both private and public hospitals for treating through neurology will further boost for the neuromodulation market.

Impact of COVID-19 on Neuromodulation Devices

The outbreak of COVID-19 has a positive impact on the Neuromodulation Devices Market. The pandemic is causing a increase in chronic diseases like depression, epilepsy and spinal problem etc. within the population. However the market was expected to raise even earlier the covid pandemic, this pandemic has only aided the neuromodulation devices market to rise. The vagus nerve stimulation is one of the highest used applications to treat covid related respiratory problems. Utmost of the Covid infected patients will have pneumonia (an inflammation owing to contagion in one or both lung's air sacs). This treatment comprises delivering electrical pulses to the vagus nerve to treat the acute respiratory disease. Due to this there is a massive rise in funds in both private and public hospitals for neurology applications to help treat the illness.

By End User

Specialty Clinics Segment, Dominate the Market in 2024

The specialty clinics segment made huge revenue in 2024 and growing its prominence during the forecast period. There is an obvious shift in patient treatment in outpatient settings, globally. The main reasons for this shift comprise over-occupancy of hospital inpatient settings and a reduction in the number of hospitals and hospital beds in urbanized countries. The regional and national agencies lay weight on the treatment of patients either at home or in outpatient clinics. The origination of specialty clinics for cardiology, neurology, and other conditions in developed and developing countries is enticing a large patient pool suffering from acute and chronic conditions. Besides this, along with acceptance of innovative instruments, skilled staff, and adequate reimbursement policies for treatment in these settings, has led to the growing number of patients visiting specialty clinics for the cure of chronic pain, epilepsy, and other conditions.

By Geography

North America Region is Leading in the Global Market Place

North America is likely to have a huge demand in the forecast period. The main reasons accountable for the governance of the province comprise greater diagnosis and treatment rates between the patient population and greater acceptance of neuromodulation devices for the treatment of prolonged conditions. This is further increased by the higher occurrence of chronic conditions in the U.S. and sufficient reimbursement policies for these devices in the country.

List of the Key Players Profiled in the Market Include:

• Abbott
• Advanced Bionics
• B Braun
• Boston Scientific Corporation
• Cyberonics LivaNova
• electroCore Medical
• LivaNova PLC
• Medtronic
• Neuronetics Inc.
• Neurosigma Inc.
• Nevro
• Nuvectra
• St. Jude Medical, Inc.
• Teleflex

List of the Regions/Countries Profiled in the Market Include:

North America
• US
• Canada
• Mexico
Europe
• Germany
• U.K
• Italy
• France
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• New Zealand
• Rest of Asia Pacific
Middle East
• Saudi Arabia
• UAE
• Rest of Middle East
Latin America
• Argentina
• Brazil
• Rest of Latin America
Rest of the World (RoW)
• South Africa
• Others